Physician profile

Lezley R Brown

Family Medicine · Rocklin, CA

NPI 1033202650

$1,524.30

in general payments reported to CMS, 2019-2025

22 companies · $162 in 2025

The $162 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).

See the full distribution for Family Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$491.56

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Ibsa Pharma INC. $615.62 2019-2022
Mayne Pharma Commercial LLC $176.83 2023-2025
Abbvie INC. $171.95 2022-2025 Vraylar, Qulipta
Novo Nordisk INC $91.45 2019-2020
Pfizer INC. $75.90 2022-2025
Alexion Pharmaceuticals, INC. $56.02 2024 Koselugo
Glaxosmithkline, LLC. $47.82 2020-2023 Arexvy, Shingrix
Lilly USA, LLC $35.60 2020-2022
Fidia Pharma USA INC. $33.48 2025 Hymovis
Noctrix Health, INC. $22.06 2025 Nidra
Depuy Synthes Sales INC. $21.61 2024 Orthovisc, Monovisc
Endo Pharmaceuticals INC. $19.61 2019
Kaleo, INC. $18.84 2020
Exact Sciences Corporation $18.79 2025 Cologuard Collection Kit
Allergan, INC. $18.58 2020
Show all 22 companies
CompanyGeneral paymentsYearsTop products
Philips North America LLC $17.25 2019
Genentech USA, INC. $16.79 2019
Therapeuticsmd, INC. $14.13 2019
Amgen INC. $13.48 2022
Idorsia Pharmaceuticals US INC $13.46 2023 Quviviq
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $12.64 2019
Hologic Sales and Service, LLC $12.39 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Lezley R Brown

$1,524.30

in general payments reported 2019-2025

Years
2019-2025
Top company
Ibsa Pharma INC.
Context
The $162 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).

https://glasscript.com/doctor/273972/lezley-r-brown

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.